Cost-effectiveness of Whole Genome Sequencing of Healthy Adults

Address, Adult, Area, base, behavioral response, Benign, Big Data, career, career development, Caring, Classification, Clinical, clinical care, clinical development, Clinical Trials, Conduct Clinical Trials, cost, Cost Analysis, cost effective, cost effectiveness, Cost effectiveness research, Cost utility, Data, data modeling, Decision Making, Decision Modeling, Development, Diagnostic tests, Disclosure, Disease, disorder risk, DNA Sequence, economic implication, etiology, Evaluation, experience, falls, Family, follow-up, Foundational Skills, Foundations, Funding, Future, Genetic, genome sequencing, Genomics, Goals, Grant, Guidelines, Health, Health Care Costs, Health Expenditures, Health Technology, Healthcare, high risk, improved, Incidental Findings, Individual, Inherited, innovation, insight, Institution, instructor, International, Intervention, large datasets, Lead, Medical, mendelian disorder, Mentors, Modeling, Monitor, National Human Genome Research Institute, National Research Service Awards, novel, Outcome, Participant, Pathogenicity, Patient Care, Patient-Focused Outcomes, Patients, Peer Review, Penetrance, Periodicity, pharmacogenomics, Physicians, Policies, Population, Predisposition, Prevention, Primary Health Care, Principal Investigator, Process, programs, psychologic, Publications, Publishing, Quality-Adjusted Life Years, Randomized Clinical Trials, Randomized Controlled Trials, randomized trial, Recording of previous events, reproductive, Research, Research Personnel, Research Training, Reservations, response, Risk, screening, Services, side effect, skills, skills training, symposium, Syndrome, Technology Assessment, Testing, Time, treatment as usual, treatment choice, Uncertainty, United States National Institutes of Health, Variant, whole genome